Bussini, Linda
 Distribuzione geografica
Continente #
NA - Nord America 1.755
AS - Asia 944
EU - Europa 303
SA - Sud America 187
Continente sconosciuto - Info sul continente non disponibili 59
AF - Africa 22
OC - Oceania 1
Totale 3.271
Nazione #
US - Stati Uniti d'America 1.708
SG - Singapore 468
CN - Cina 187
BR - Brasile 141
VN - Vietnam 125
IT - Italia 108
HK - Hong Kong 41
CA - Canada 30
GB - Regno Unito 30
IN - India 26
DE - Germania 24
FI - Finlandia 24
IE - Irlanda 24
FR - Francia 19
NL - Olanda 18
MY - Malesia 15
ES - Italia 12
CO - Colombia 9
EC - Ecuador 9
JP - Giappone 9
PL - Polonia 8
AR - Argentina 7
AT - Austria 7
BD - Bangladesh 7
ID - Indonesia 7
IQ - Iraq 7
PE - Perù 7
ZA - Sudafrica 7
EG - Egitto 6
KR - Corea 6
MX - Messico 6
SA - Arabia Saudita 6
TR - Turchia 6
CL - Cile 5
VE - Venezuela 5
BG - Bulgaria 4
BH - Bahrain 4
PH - Filippine 4
PK - Pakistan 4
RU - Federazione Russa 4
SE - Svezia 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
GR - Grecia 3
IR - Iran 3
MA - Marocco 3
PY - Paraguay 3
TW - Taiwan 3
UZ - Uzbekistan 3
GT - Guatemala 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
SK - Slovacchia (Repubblica Slovacca) 2
UA - Ucraina 2
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
HT - Haiti 1
KE - Kenya 1
KG - Kirghizistan 1
LT - Lituania 1
LV - Lettonia 1
MU - Mauritius 1
NI - Nicaragua 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TM - Turkmenistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 3.212
Città #
Dallas 439
Singapore 172
Ashburn 157
San Jose 124
Santa Clara 68
The Dalles 67
Council Bluffs 62
Beijing 55
Ho Chi Minh City 46
Los Angeles 46
Shanghai 41
New York 40
Hong Kong 36
Milan 34
Boardman 32
Dublin 23
Phoenix 23
Helsinki 22
Hanoi 19
Buffalo 16
Chicago 15
São Paulo 14
Chennai 13
Kuala Lumpur 10
Amsterdam 9
Atlanta 9
Haiphong 8
London 8
Queens 8
Rio de Janeiro 8
Rome 8
Boston 7
Brooklyn 7
Cuenca 7
Denver 7
Toronto 7
Cairo 6
Charlotte 6
Da Nang 6
Genoa 6
Montreal 6
Philadelphia 6
Riverside 6
Seattle 6
Naples 5
Orem 5
São Luís 5
Warsaw 5
Belfast 4
Brasília 4
Bắc Ninh 4
Jeddah 4
Newark 4
Sacramento 4
Santiago 4
The Bronx 4
Tokyo 4
Vienna 4
Abbeville 3
Albuquerque 3
Anaheim 3
Ankara 3
Bologna 3
Can Tho 3
Chapel Hill 3
Charlemont 3
Frankfurt am Main 3
Grumo Nevano 3
Houston 3
Jacksonville 3
Knoxville 3
Louisville 3
Madrid 3
Manama 3
Medellín 3
Medolla 3
Mexico City 3
Miami 3
Nuremberg 3
Paris 3
Princeton 3
Raleigh 3
Ribeirão Preto 3
San Antonio 3
Sofia 3
Tashkent 3
Tucson 3
Amman 2
Ancona 2
Arequipa 2
Arlington 2
Athens 2
Baghdad 2
Barcelona 2
Bekasi 2
Belo Horizonte 2
Bogotá 2
Bowie 2
Boydton 2
Bristol 2
Totale 1.888
Nome #
What is the impact of anti-enterococcal empirical therapy on survival of patients with enterococcal bloodstream infections? 459
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 193
Beyond the distance between juridic and scientific decision-making process: An evidence-based prediction algorithm for professional liability assessment in healthcare-associated infections 137
Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study 113
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future 103
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS‐CoV‐2 infection 103
Epidemiology and Resistance Profiles of Bacteria Isolated From Blood Samples in Septic Patients at Emergency Department Admission: A 6-Year Single Centre Retrospective Analysis From Northern Italy 87
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study 82
Distinct chromosomal mutation associated with cefiderocol resistance in Acinetobacter baumannii: a combined bioinformatics and mass spectrometry approach to unveil and validate the in vivo-acquired chemoresistance 68
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 68
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 64
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 61
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 61
ESCMID COVID-19 living guidelines: drug treatment and clinical management 59
Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018 59
Dialysis-associated infection prevention and surveillance trial: an easy, feasible and effective bundle for infection prevention 59
Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study 57
Increase in invasive group A streptococcal infections in Milan, Italy: a genomic and clinical characterization 57
Role of liposomal amphotericin B in intensive care unit: an expert opinion paper 56
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 55
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 53
What do clinicians mean by epidemics' preparedness 53
Outcome of early treatment of SARS‐CoV‐2 infection in patients with haematological disorders 52
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population 52
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 51
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 51
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections 50
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 49
Use of Aztreonam-avibactam for infections caused by MBL-producing Enterobacterales 49
Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda 48
Elevating fungal care: bridging Brazil’s healthcare practices to global standards 47
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 47
Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions 46
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 43
ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply 42
Inappropriate use of ivermectin during the COVID-19 pandemic: primum non nocere! 37
Successful treatment and secondary prophylaxis with pritelivir for a recurrent multidrug-resistant herpes simplex virus 1 infection in an allogeneic haematopoietic stem cell transplant recipient 36
Reliable timescale inference of HBV genotype A origin and phylodynamics 36
European society of clinical microbiology and infectious diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild/moderate disease 35
Why do echinocandins fail? Identifying key predictors to improve clinical outcomes of candida bloodstream infections: a retrospective multicenter cohort study 35
Risk factors for persisting SARS-CoV-2 infection in patients with B-cell malignancies in the Omicron era: A multicenter cohort study 34
Corrigendum to: “Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)” Clinical Microbiology and Infection 26 (2020) 1545–1553 32
Prevalence of metabolic syndrome in HIV-infected patients naive to antiretroviral therapy or receiving a first-line treatment 31
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 31
Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV‐1 infection 30
Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort 30
Neutralizing monoclonal antibodies for early treatment of hospital‐acquired SARS‐CoV‐2 infection in hematologic patients 30
Clinical utility of the DENOVA score for predicting infective endocarditis in Enterococcus faecalis bacteraemia: external validation with decision curve analysis 23
Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study) 20
Monotherapy vs. combination therapy for Enterococcus faecalis bacteraemia: a target trial emulation 19
Primary Therapy for Invasive Aspergillosis With Triazoles or L-AmB: A Multicenter Retrospective Study 17
Real-world use of cefiderocol as monotherapy or combination therapy for the treatment of Gram-negative bacterial infections: the multicentre retrospective CEFI-BAC study 16
Anti–Methicillin-Resistant Staphylococcus aureus (MRSA) Cephalosporins Plus Daptomycin as Initial Therapy for MRSA Bacteremia: Does a “Hit Hard and Fast” Strategy Improve Outcomes? 16
Clinical utility of the DENOVA score for predicting infective endocarditis in Enterococcus faecalis bacteraemia—Author's reply 15
Reply to Comment on “Why do echinocandins fail? Identifying key predictors to improve clinical outcomes of Candida bloodstream infections: A retrospective multicenter cohort study” 14
Totale 3.271
Categoria #
all - tutte 14.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.681


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202323 0 0 0 0 0 0 0 0 0 0 20 3
2023/2024240 13 11 43 8 13 41 12 18 7 17 28 29
2024/2025397 11 0 3 11 14 47 31 21 81 104 31 43
2025/20261.873 126 143 370 115 140 108 317 104 100 120 106 124
2026/2027738 269 119 281 69 0 0 0 0 0 0 0 0
Totale 3.271